Clinical application of Chamomilla recutita in phlebitis: dose response curve study Aplicación clínica de la Chamomilla recutita en flebitis: estudio de la curva dosis-respuesta Aplicação clínica da Chamomilla recutita em flebites: estudo de curva dose-resposta

Autor: Paula Elaine Diniz dos Reis, Emilia Campos de Carvalho, Paula Carolina Pires Bueno, Jairo Kenupp Bastos

Publikováno v: Revista Latino-Americana de Enfermagem, Vol 19, Iss 1, Pp 03-10 (2011)

This experimental and dose-response curve study aimed to carry out the quality control of the Chamomilla recutita sample, as well as to estimate the ideal dose, for anti-inflammatory effect, of the extract of its capitula, in patients with phlebitis

Externí odkaz: https://doaj.org/article/c75c50250cb54465bdc86167ff7fa488

Gabapentina y reducción del dolor por mucositis oral inducida por radioterapia en cáncer de faringe en el Hospital Nacional Edgardo Rebagliati Martins 2019-2021

Autor: Simón Romero, Sonia Elizabeth

Publikováno v: Universidad de San Martín de Porres – USMP
REPOSITORIO ACADÉMICO USMP
USMP-Institucional
Universidad de San Martín de Porres
instacron:USMP

Objetivo general: Establecer la relación entre el uso de gabapentina y la reducción del dolor por mucositis oral inducida por radioterapia en pacientes con cáncer de faringe en el Hospital Nacional Edgardo Rebagliati Martins 2019-2021. La incidenc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3056::c2aad51e0d5d8cf9414db12e46a6b738

Increased Soluble Fas Plasma Levels in Subjects at High Cardiovascular Risk

Autor: Eduardo de Teresa, Jesús Egido, Allan Gaw, Pierre Martineau, Gonzalo Hernández, Csaba Farsang, Lawrence A. Leiter, José Luis Martín-Ventura, Anatoly Langer, Luis Miguel Blanco-Colio, Gian Franco Gensini

Publikováno v: Arteriosclerosis, Thrombosis, and Vascular Biology. 27:168-174

Objectives— Increasing evidence indicates that the Fas/Fas ligand interaction is involved in atherogenesis. We sought to analyze soluble Fas (sFas) and soluble Fas ligand (sFasL) concentrations in subjects at high cardiovascular risk and their modu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be1f60518cd502e49ea3aa197afe4a54
https://doi.org/10.1161/01.atv.0000250616.26308.d7

Control del vector del dengue utilizando fracciones etéreas de dos plantas (Asteraceae) como larvicidas

Autor: Álvarez-Londoño, Juan C., Duarte-Gandica, Irene, Aguirre-Obando, Oscar A., Jiménez-Montoya, Jorge A.

Publikováno v: Revista de Salud Pública, Volume: 15, Issue: 2, Pages: 227-236, Published: MAR 2013

Objetivo Evaluar la actividad larvicida de dos fracciones etéreas de Heli opsisoppositifolia (L.) Drucey Jaegeria hirta (Lag.) Less en larvas de Aedes (Stegomyia) aegypti (L.) de 3-4 ínstar, en el municipio de Armenia, Quindio. Métodos Se realizó

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______618::6bfa6d4490cfaa3e19cf21fb5707f61b
http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0124-00642013000200006&lng=en&tlng=en

Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis

Autor: Tobias Derfuss, Tomas Kalincik, Timothy Spelman, Maria Trojano, Pierre Duquette, Guillermo Izquierdo, Pierre Grammond, LUGARESI, ALESSANDRA, Raymond Hupperts, Edgardo Cristiano, Vincent Van Pesch, Francois Grand’Maison, Daniele La Spitaleri, Maria Edite Rio, Sholmo Flechter, Celia Oreja Guevara, Giorgio Giuliani, Aldo Savino, Maria Pia Amato, Thor Petersen, Ricardo Fernandez Bolanos, Roberto Bergamaschi, Gerardo Iuliano, Cavit Boz, Jeannette Lechner Scott, Norma Deri, Orla Gray, Freek Verheul, Marcela Fiol, Michael Barnett, Erik van Munster, Vetere Santiago, Fraser Moore, Mark Slee, Maria Laura Saladino, Raed Alroughani, Cameron Shaw, Krisztian Kasa, Tatjana Petkovska Boskova, Leontien den Braber Moerland, Joab Chapman, Eli Skromne, Joseph Herbert, Dieter Poehlau, Merrilee Needham, Elizabeth Alejandra Bacile Bacile, Walter Oleschko Arruda, Mark Paine, Bhim Singhal, Steve Vucic, Jose Antonio Cabrera Gomez, Helmut Butzkueven, MSBase Study Group

Publikováno v: PLOS ONE, 8(5):e63480. Public Library of Science
PLoS One, Vol. 8, no.5, p. e63480 (2013)
PLoS ONE, Vol 8, Iss 5, p e63480 (2013)
Kalincik, T, Spelman, T, Trojano, M, Duquette, P, Izquierdo, G, Grammond, P, Lugaresi, A, Hupperts, R, Cristiano, E, Van Pesch, V, Grand'maison, F, La Spitaleri, D, Rio, M E, Flechter, S, Oreja-Guevara, C, Giuliani, G, Savino, A, Amato, M P, Petersen, T, Fernandez-Bolanos, R, Bergamaschi, R, Iuliano, G, Boz, C, Lechner-Scott, J, Deri, N, Gray, O, Verheul, F, Fiol, M, Barnett, M, van Munster, E, Santiago, V, Moore, F, Slee, M, Saladino, M L, Alroughani, R, Shaw, C, Kasa, K, Petkovska-Boskova, T, den Braber-Moerland, L, Chapman, J, Skromne, E, Herbert, J, Poehlau, D, Needham, M, Bacile, E A B, Arruda, W O, Paine, M, Singhal, B, Vucic, S, Cabrera-Gomez, J A & MSBase Study Group 2013, ' Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis ', PLOS ONE, vol. 8, no. 5, e63480 . https://doi.org/10.1371/journal.pone.0063480
PLoS ONE

Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; OBJECTIVES To compare treatment persistence between two dosages of interferon β-1a in a large observational multiple sclerosis registry and assess disease outcomes

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7bcd296547811d4f2d94e8e91d7dd7b
https://cris.maastrichtuniversity.nl/en/publications/27af1adb-344e-4c96-81d5-1c1bb29fd1fc